82 related articles for article (PubMed ID: 9531381)
21. Oncolytic activity of NK cells against SW-756 squamous cervical carcinoma cell line: role of interferons alpha and gamma and CD54 adhesion molecule in oncolysis.
Cristoforoni PM; Lotzová E; Cook KR; Chuang LT; Morris M; Grossi CE; Wharton JT
Gynecol Oncol; 1994 Mar; 52(3):365-72. PubMed ID: 7512522
[TBL] [Abstract][Full Text] [Related]
22. The effectors of killer activity induced by interferon-alpha and gamma in peripheral blood mononuclear cells.
Sakaguchi M; Kubota S; Nishikido M; Taniguchi K; Inuzuka S; Saito Y; Kanetake H; Koga S
Int J Mol Med; 2002 Sep; 10(3):317-20. PubMed ID: 12165807
[TBL] [Abstract][Full Text] [Related]
23. Medullasin enhances human natural killer cell activity by a mechanism other than the induction of interferons or interleukin-2.
Aoki Y; Fukuchi K
Jpn J Cancer Res; 1987 Jan; 78(1):68-73. PubMed ID: 2434455
[TBL] [Abstract][Full Text] [Related]
24. Polymorphic radiation sensitivity of human natural killer activity: possible role of DNA strand breakage.
Schacter B; Hansal S; Arno J; LeVine MJ
Hum Immunol; 1985 Sep; 14(1):49-58. PubMed ID: 3161853
[TBL] [Abstract][Full Text] [Related]
25. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
Chalan P; Bijzet J; Kroesen BJ; Boots AM; Brouwer E
J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380
[TBL] [Abstract][Full Text] [Related]
26. The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.
Gibson PR; Jewell DP
Clin Exp Immunol; 1985 Jul; 61(1):160-8. PubMed ID: 2412737
[TBL] [Abstract][Full Text] [Related]
27. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
[TBL] [Abstract][Full Text] [Related]
28. Effect of 4-hydroxynonenal, a product of lipid peroxidation, on NK susceptibility of human K562 target cells.
Rinaldi M; Tricarico M; Bonmassar E; Parrella P; Barrera G; Fazio VM
Anticancer Res; 1998; 18(5A):3591-5. PubMed ID: 9858944
[TBL] [Abstract][Full Text] [Related]
29. The effect of recombinant alpha 2-interferon on defective natural killer cell activity in multiple sclerosis.
Hirsch RL; Johnson KP
Neurology; 1985 Apr; 35(4):597-600. PubMed ID: 3982654
[TBL] [Abstract][Full Text] [Related]
30. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
31. Effect of D-glucosamine on human natural killer activity in vitro.
Matheson DS; Green BJ; Friedman SJ
J Biol Response Mod; 1984 Aug; 3(4):445-53. PubMed ID: 6207272
[TBL] [Abstract][Full Text] [Related]
32. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
33. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
34. In vitro interactions of purified cloned human interferons on NK cells: enhanced activation.
Targan S; Stebbing N
J Immunol; 1982 Sep; 129(3):934-5. PubMed ID: 6180004
[No Abstract] [Full Text] [Related]
35. Effect of retinoic acid on the spontaneous and interferon-induced activity of human natural killer cells.
Abb J; Abb H; Deinhardt F
Int J Cancer; 1982 Sep; 30(3):307-10. PubMed ID: 6182114
[TBL] [Abstract][Full Text] [Related]
36. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity.
Sone S; Utsugi T; Nii A; Ogura T
J Natl Cancer Inst; 1988 May; 80(6):425-31. PubMed ID: 3130488
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
39. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
[TBL] [Abstract][Full Text] [Related]
40. Basic and interferon-augmented natural killer (NK) cell activity in psoriasis.
Jansén CT; Viander M
Acta Derm Venereol; 1983; 63(5):384-7. PubMed ID: 6197835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
